Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort
European Urology Focus · 2026
DOI: 10.1016/j.euf.2025.04.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Urology Focus, 2026. Verfasst von Kevin Shee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of California-San Francisco, San Francisco, CA, USA. Electronic address: kevin.shee@ucsf.edu. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: University of California, San Francisco.
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVE: A biopsy diagnosis of Gleason grade group (GG) 3 prostate cancer (PC) automatically classifies patients as having at least unfavorable intermediate-risk disease warranting definitive treatment. We hypothesized that GG3 PCs are not equally unfavorable. METHODS: The Urologic Outcomes Database at University of California-San Francisco was queried for men with localized, nonmetastatic PC diagnosed after 2000 who underwent radical prostatectomy (RP). The primary outcome was recurrence, defined as either biochemical failure (two prostate-specific antigen results ≥0.2 ng/ml) or salvage treatment. Multivariable Cox proportional-hazards regression models were used to calculate associations with the risk of recurrence, adjusted for clinicodemographic and postoperative factors. KEY FINDINGS AND LIMITATIONS: We included 4934 men who underwent RP in the analysis, of whom 862 (17%) were diagnosed with GG3 PC on biopsy. Cancer of the Prostate Risk Assessment postsurgery (CAPRA-S) scores overall increased over time, but remained broadly distributed. Multivariable analysis controlled for postoperative factors with CAPRA-S revealed that favorable biopsy Gleason histology (not expansile cribriform or intraductal carcinoma) was the strongest factor associated with lower risk of recurrence after RP (hazard ratio [HR] 0.61, 95% confidence interval [CI] 0.41-0.91), independent of the percentage of pattern 4. A higher percentage of positive cores (PPC) was also significantly associated with the risk of recurrence (HR per 10% increment: 1.06, 95% CI 1.01-1.11). Limitations include the retrospective nature of the single-institution study and the homogeneous study population. CONCLUSIONS AND CLINICAL IMPLICATIONS: Patients with GG3 PC on diagnostic biopsy have heterogeneous risk. Unfavorable biopsy histology and higher PPC were significantly associated with the risk of recurrence after RP after controlling for CAPRA-S scores. Not all GG3 cancers are equally unfavorable, and differential management may be warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, University of California-San Francisco, San Francisco, CA, USA. Electronic address: kevin.shee@ucsf.edu.
- Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
- Department of Pathology, University of California-San Francisco, San Francisco, CA, USA.
- Department of Urology, University of California-San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, CA, USA.
Förderung
- University of California, San Francisco
Zitieren
APA
Shee, K., Cowan, J. E., Ding, C. C., Wang, L., Pace, W., Greenland, N., Simko, J. P., Washington, S. L., Shinohara, K., Nguyen, H. G., Cooperberg, M. R., & Carroll, P. R. (2026). Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort. European Urology Focus. https://doi.org/10.1016/j.euf.2025.04.027
Vancouver
Shee K, Cowan JE, Ding CC, Wang L, Pace W, Greenland N, et al. Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort. European Urology Focus. 2026. doi:10.1016/j.euf.2025.04.027
BibTeX
@article{Shee2026,
author = {Shee, Kevin and Cowan, Janet E and Ding, Chien-Kuang Cornelia and Wang, Lufan and Pace, William and Greenland, Nancy and Simko, Jeffry P and Washington, Samuel L and Shinohara, Katsuto and Nguyen, Hao G and Cooperberg, Matthew R and Carroll, Peter R},
title = {Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort},
journal = {European Urology Focus},
year = {2026},
doi = {10.1016/j.euf.2025.04.027}
}
EUVIMED